BS-181 dihydrochloride (intraperitoneal injection; 10 mg/kg, 20 mg/kg; single dose) is well tolerated in mice without apparent weight altering[1].BS-181 dihydrochloride (intraperitoneal injection; 5 mg/kg or 10 mg/kg twice daily; total daily doses of 10 mg/kg or 20 mg/kg; 14 days) inhibitstumor growth in a dose-dependent manner. Tumor growth exhibits 25% and 50% reduction compared with the control group, for 10 mg/kg/day and 20 mg/kg/day, respectively[1].
| Animal Model: | 7-week old female nu/nu-BALB/c athymic nude mice?with MCF-7 cells[1] |
| Dosage: | 5 mg/kg or 10 mg/kg; 10 mg/kg or 20 mg/kg |
| Administration: | Intraperitoneal injection; twice daily or once total daily; 14 days |
| Result: | Inhibited tumor growth significantly. |